Suppr超能文献

多能干细胞衍生的心肌细胞的旁分泌作用挽救受损心肌。

Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.

作者信息

Tachibana Atsushi, Santoso Michelle R, Mahmoudi Morteza, Shukla Praveen, Wang Lei, Bennett Mihoko, Goldstone Andrew B, Wang Mouer, Fukushi Masahiro, Ebert Antje D, Woo Y Joseph, Rulifson Eric, Yang Phillip C

机构信息

From the Division of Cardiovascular Medicine (A.T., M.R.S., M.M., P.S., L.W., M.W., A.D.E., E.R., P.C.Y.), Division of Neonatal and Developmental Medicine (M.B.), and Department of Cardiothoracic Surgery (A.B.G., Y.J.W.), Stanford University, CA; Department of Radiological Sciences, Tokyo Metropolitan University, Japan (A.T., M.F.); Department of Critical Care Medicine, 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine, China (L.W.); Department of Cardiology and Pneumonology, Göttingen University Medical Center, Germany (A.D.E.); and German Center for Cardiovascular Research, Partner Site Göttingen, Germany (A.D.E.).

出版信息

Circ Res. 2017 Sep 1;121(6):e22-e36. doi: 10.1161/CIRCRESAHA.117.310803. Epub 2017 Jul 25.

Abstract

RATIONALE

Cardiac myocytes derived from pluripotent stem cells have demonstrated the potential to mitigate damage of the infarcted myocardium and improve left ventricular ejection fraction. However, the mechanism underlying the functional benefit is unclear.

OBJECTIVE

To evaluate whether the transplantation of cardiac-lineage differentiated derivatives enhance myocardial viability and restore left ventricular ejection fraction more effectively than undifferentiated pluripotent stem cells after a myocardial injury. Herein, we utilize novel multimodality evaluation of human embryonic stem cells (hESCs), hESC-derived cardiac myocytes (hCMs), human induced pluripotent stem cells (iPSCs), and iPSC-derived cardiac myocytes (iCMs) in a murine myocardial injury model.

METHODS AND RESULTS

Permanent ligation of the left anterior descending coronary artery was induced in immunosuppressed mice. Intramyocardial injection was performed with (1) hESCs (n=9), (2) iPSCs (n=8), (3) hCMs (n=9), (4) iCMs (n=14), and (5) PBS control (n=10). Left ventricular ejection fraction and myocardial viability, measured by cardiac magnetic resonance imaging and manganese-enhanced magnetic resonance imaging, respectively, was significantly improved in hCM- and iCM-treated mice compared with pluripotent stem cell- or control-treated mice. Bioluminescence imaging revealed limited cell engraftment in all treated groups, suggesting that the cell secretions may underlie the repair mechanism. To determine the paracrine effects of the transplanted cells, cytokines from supernatants from all groups were assessed in vitro. Gene expression and immunohistochemistry analyses of the murine myocardium demonstrated significant upregulation of the promigratory, proangiogenic, and antiapoptotic targets in groups treated with cardiac lineage cells compared with pluripotent stem cell and control groups.

CONCLUSIONS

This study demonstrates that the cardiac phenotype of hCMs and iCMs salvages the injured myocardium effectively than undifferentiated stem cells through their differential paracrine effects.

摘要

原理

源自多能干细胞的心肌细胞已显示出减轻梗死心肌损伤并提高左心室射血分数的潜力。然而,功能益处背后的机制尚不清楚。

目的

评估心肌损伤后,与未分化的多能干细胞相比,移植心脏谱系分化衍生物是否能更有效地增强心肌活力并恢复左心室射血分数。在此,我们在小鼠心肌损伤模型中对人胚胎干细胞(hESCs)、hESC衍生的心肌细胞(hCMs)、人诱导多能干细胞(iPSCs)和iPSC衍生的心肌细胞(iCMs)进行了新型多模态评估。

方法与结果

在免疫抑制小鼠中诱导左前降支冠状动脉永久性结扎。进行心肌内注射,注射对象为:(1)hESCs(n = 9),(2)iPSCs(n = 8),(3)hCMs(n = 9),(4)iCMs(n = 14),以及(5)PBS对照组(n = 10)。与多能干细胞或对照组处理的小鼠相比,hCM和iCM处理的小鼠的左心室射血分数和心肌活力(分别通过心脏磁共振成像和锰增强磁共振成像测量)显著改善。生物发光成像显示所有处理组中的细胞植入有限,这表明细胞分泌物可能是修复机制的基础。为了确定移植细胞的旁分泌作用,在体外评估了所有组上清液中的细胞因子。与多能干细胞和对照组相比,对小鼠心肌进行的基因表达和免疫组织化学分析表明,心脏谱系细胞处理组中促迁移、促血管生成和抗凋亡靶点的表达显著上调。

结论

本研究表明,hCMs和iCMs的心脏表型通过其不同的旁分泌作用比未分化干细胞更有效地挽救受损心肌。

相似文献

1
Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
Circ Res. 2017 Sep 1;121(6):e22-e36. doi: 10.1161/CIRCRESAHA.117.310803. Epub 2017 Jul 25.
3
Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium.
Circ Res. 2015 Mar 27;116(7):e40-50. doi: 10.1161/CIRCRESAHA.116.304668. Epub 2015 Feb 5.
4
Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
PLoS One. 2017 May 11;12(5):e0173222. doi: 10.1371/journal.pone.0173222. eCollection 2017.
5
Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.
Circ Res. 2018 Jan 19;122(2):296-309. doi: 10.1161/CIRCRESAHA.117.311769. Epub 2017 Nov 8.
6
Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.
Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H327-H339. doi: 10.1152/ajpheart.00688.2017. Epub 2018 Apr 6.
7
Exosomes From Induced Pluripotent Stem Cell-Derived Cardiomyocytes Promote Autophagy for Myocardial Repair.
J Am Heart Assoc. 2020 Mar 17;9(6):e014345. doi: 10.1161/JAHA.119.014345. Epub 2020 Mar 5.
8
Multimodal Imaging for In Vivo Evaluation of Induced Pluripotent Stem Cells in a Murine Model of Heart Failure.
Artif Organs. 2017 Feb;41(2):192-199. doi: 10.1111/aor.12728. Epub 2016 Jun 14.

引用本文的文献

1
Geometrically controlled cardiac microtissues promote vascularization and reduce inflammation and .
Cell Biomater. 2025 May 27;1(4). doi: 10.1016/j.celbio.2025.100075. Epub 2025 Apr 29.
3
Stem Cell Therapy in Ischemic Heart Failure.
Am J Cardiovasc Drugs. 2025 Jun 27. doi: 10.1007/s40256-025-00741-0.
4
Injectable Stem Cell-Based Therapies for Myocardial Regeneration: A Review of the Literature.
J Funct Biomater. 2025 Apr 23;16(5):152. doi: 10.3390/jfb16050152.
7
Partial Cell Fate Transitions to Promote Cardiac Regeneration.
Cells. 2024 Dec 4;13(23):2002. doi: 10.3390/cells13232002.
8
Extracellular vesicle therapeutics for cardiac repair.
J Mol Cell Cardiol. 2025 Feb;199:12-32. doi: 10.1016/j.yjmcc.2024.11.005. Epub 2024 Nov 26.
9
Myocardial infarction in rats was alleviated by MSCs derived from the maternal segment of the human umbilical cord.
Front Cell Dev Biol. 2024 Oct 16;12:1469541. doi: 10.3389/fcell.2024.1469541. eCollection 2024.
10
Cardiomyopathy: pathogenesis and therapeutic interventions.
MedComm (2020). 2024 Oct 25;5(11):e772. doi: 10.1002/mco2.772. eCollection 2024 Nov.

本文引用的文献

1
Thrombospondins in the transition from myocardial infarction to heart failure.
J Mol Cell Cardiol. 2016 Jan;90:102-10. doi: 10.1016/j.yjmcc.2015.12.009. Epub 2015 Dec 10.
2
The winding road to regenerating the human heart.
Cardiovasc Pathol. 2015 May-Jun;24(3):133-40. doi: 10.1016/j.carpath.2015.02.004. Epub 2015 Feb 19.
3
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.
Circulation. 2015 Jan 27;131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17.
5
Chemically defined generation of human cardiomyocytes.
Nat Methods. 2014 Aug;11(8):855-60. doi: 10.1038/nmeth.2999. Epub 2014 Jun 15.
6
Maternal nutrient restriction during pregnancy impairs an endothelium-derived hyperpolarizing factor-like pathway in sheep fetal coronary arteries.
Am J Physiol Heart Circ Physiol. 2014 Jul 15;307(2):H134-42. doi: 10.1152/ajpheart.00595.2013. Epub 2014 May 9.
7
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.
Nature. 2014 Jun 12;510(7504):273-7. doi: 10.1038/nature13233. Epub 2014 Apr 30.
8
Paracrine effects of stem cells in wound healing and cancer progression (Review).
Int J Oncol. 2014 Jun;44(6):1789-98. doi: 10.3892/ijo.2014.2385. Epub 2014 Apr 11.
9
Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.
Mol Cancer Res. 2014 Jun;12(6):953-64. doi: 10.1158/1541-7786.MCR-13-0668. Epub 2014 Mar 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验